814262-90-3 Usage
Uses
Used in Scientific Research:
5-Bromo-2-hydroxy-4,6-dimethyl-nicotinonitrile is used as a research compound for its unique structural features, which may contribute to the development of new chemical entities or the study of chemical reactions and interactions.
Used in Industrial Applications:
5-Bromo-2-hydroxy-4,6-dimethyl-nicotinonitrile is used as an intermediate in the synthesis of various industrial products, such as pharmaceuticals, agrochemicals, or specialty chemicals, due to its reactive functional groups and potential for further modification.
Used in Drug Development:
5-Bromo-2-hydroxy-4,6-dimethyl-nicotinonitrile is used as a lead compound in the development of new drugs, particularly in the field of medicinal chemistry, where its structural properties may be exploited to design novel therapeutic agents with potential applications in various diseases and conditions.
Used in Material Science:
5-Bromo-2-hydroxy-4,6-dimethyl-nicotinonitrile is used as a component in the synthesis of advanced materials, such as polymers, coatings, or composites, where its chemical properties may contribute to the desired material characteristics, such as stability, reactivity, or functionality.
Check Digit Verification of cas no
The CAS Registry Mumber 814262-90-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,1,4,2,6 and 2 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 814262-90:
(8*8)+(7*1)+(6*4)+(5*2)+(4*6)+(3*2)+(2*9)+(1*0)=153
153 % 10 = 3
So 814262-90-3 is a valid CAS Registry Number.
814262-90-3Relevant academic research and scientific papers
NOVEL COMPOUNDS
-
Page/Page column 60, (2011/04/25)
The present invention discloses novel compounds inhibiting LRRK2 kinase activity, the preparation processes thereof, the compositions containing them, as well as the use in treating diseases characterized by LRRK2 kinase activity, particularly Parkinson's disease and Alzheimer's disease.
